Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase

Clin Chem Lab Med. 2024 Jul 15;63(1):e11-e15. doi: 10.1515/cclm-2024-0523. Print 2025 Jan 29.

Franz L Knörnschild¹, Sven Liebig², Peggy Kießling³, Monika Prpic¹, Tehyung Kim², Ulrich Keller^{2

4

5}, Kai Kappert^{1

3}, Stefan Schwartz^{2

4}, Amir Jahic^{1

3}

¹ Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
³ Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.
⁴ German Cancer Consortium (DKTK), Partner Site Berlin, A Partnership Between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.
⁵ Max-Delbrück-Center, Berlin, Germany.

No abstract available

Keywords: drug monitoring; glucarpidase; kidney failure; methotrexate.

Publication types